Aicardi-Goutieres syndrome

Revision as of 14:36, 13 January 2009 by Zorkun (talk | contribs)
Jump to navigation Jump to search
Aicardi-Goutieres syndrome
OMIM 225750
DiseasesDB 31680

WikiDoc Resources for Aicardi-Goutieres syndrome

Articles

Most recent articles on Aicardi-Goutieres syndrome

Most cited articles on Aicardi-Goutieres syndrome

Review articles on Aicardi-Goutieres syndrome

Articles on Aicardi-Goutieres syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Aicardi-Goutieres syndrome

Images of Aicardi-Goutieres syndrome

Photos of Aicardi-Goutieres syndrome

Podcasts & MP3s on Aicardi-Goutieres syndrome

Videos on Aicardi-Goutieres syndrome

Evidence Based Medicine

Cochrane Collaboration on Aicardi-Goutieres syndrome

Bandolier on Aicardi-Goutieres syndrome

TRIP on Aicardi-Goutieres syndrome

Clinical Trials

Ongoing Trials on Aicardi-Goutieres syndrome at Clinical Trials.gov

Trial results on Aicardi-Goutieres syndrome

Clinical Trials on Aicardi-Goutieres syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Aicardi-Goutieres syndrome

NICE Guidance on Aicardi-Goutieres syndrome

NHS PRODIGY Guidance

FDA on Aicardi-Goutieres syndrome

CDC on Aicardi-Goutieres syndrome

Books

Books on Aicardi-Goutieres syndrome

News

Aicardi-Goutieres syndrome in the news

Be alerted to news on Aicardi-Goutieres syndrome

News trends on Aicardi-Goutieres syndrome

Commentary

Blogs on Aicardi-Goutieres syndrome

Definitions

Definitions of Aicardi-Goutieres syndrome

Patient Resources / Community

Patient resources on Aicardi-Goutieres syndrome

Discussion groups on Aicardi-Goutieres syndrome

Patient Handouts on Aicardi-Goutieres syndrome

Directions to Hospitals Treating Aicardi-Goutieres syndrome

Risk calculators and risk factors for Aicardi-Goutieres syndrome

Healthcare Provider Resources

Symptoms of Aicardi-Goutieres syndrome

Causes & Risk Factors for Aicardi-Goutieres syndrome

Diagnostic studies for Aicardi-Goutieres syndrome

Treatment of Aicardi-Goutieres syndrome

Continuing Medical Education (CME)

CME Programs on Aicardi-Goutieres syndrome

International

Aicardi-Goutieres syndrome en Espanol

Aicardi-Goutieres syndrome en Francais

Business

Aicardi-Goutieres syndrome in the Marketplace

Patents on Aicardi-Goutieres syndrome

Experimental / Informatics

List of terms related to Aicardi-Goutieres syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Aicardi-Goutieres syndrome is a rare genetic disorder. It is also known as Cree encephalitis and pseudo-TORCH syndrome, both of which were once considered separate disorders.[1] It is a type of leukodystrophy and is usually fatal within the first few years.[2] It is autosomal recessive and presents within the first few weeks of life.[2]

History

Aicardi-Goutieres syndrome was initially described by Jean Aicardi and Françoise Goutières in 1984, based on observations of eight cases of early-onset progressive familial encephalopathy, with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. [3] Further clinical studies included 11 cases of early-onset progressive encephalopathy in a Cree community in Canada, described in 1988, which were given the name Cree encephalitis .

Causes

Later work mapped the Aicardi-Goutieres syndrome to chromosome 3p21 and suggested that the two, along with the pseudo-TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus types 1 and 2) syndrome were the same disorder.

The condition has been associated with TREX1.[4]

Epidemiology

Aicardi-Goutieres syndrome is very rare, with only about 50 cases having been described.

Treatment and prognosis

Current treatment is supportive, involving management of seizures and spasticity associted with the syndrome. [5]

See also

References

  1. Online Mendelian Inheritance in Man (OMIM) Aicardi-Goutieres syndrome -225750
  2. 2.0 2.1 Barker, Roger A. (2005). The A-Z of Neurological Practice: A Guide to Clinical Neurology. Cambridge University Press. p. 21. ISBN 0521629608. Unknown parameter |coauthors= ignored (help)
  3. Aicardi, Jean (1984). "A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis". Ann Neuro. 15 (1): 49–54. Unknown parameter |coauthors= ignored (help)
  4. Crow YJ, Hayward BE, Parmar R; et al. (2006). "Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus". Nat. Genet. 38 (8): 917–20. doi:10.1038/ng1845. PMID 16845398. Unknown parameter |month= ignored (help)
  5. "Learning about Aicardi-Goutières Syndrome". International Aicardi-Goutières Syndrome Association. Retrieved 2008-05-21.

External links

Template:SIB


Template:WikiDoc Sources